Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics.
Saved in:
| Title: | Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics. |
|---|---|
| Authors: | Johri S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Titchen BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Graduate Program in Biological and Biomedical Sciences, Boston, MA, USA., Fu J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Conway J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Graduate Program in Bioinformatics and Integrative Genomics, Boston, MA, USA., Crowdis JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Vokes NI; Department of Thoracic and Head and Neck Oncology, MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Fan Z; Division of Hematology/Oncology, University of California, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA, USA., Fong L; Division of Hematology/Oncology, University of California, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA, USA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. eliezerm_vanallen@dfci.harvard.edu. |
| Source: | Nature communications [Nat Commun] 2025 Mar 01; Vol. 16 (1), pp. 2090. Date of Electronic Publication: 2025 Mar 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-57377-6 |
